Trial Profile
Short Term Effect of Fluvastatin on Brown Adipose Tissue Thermogenesis and Activity in Humans
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluvastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia; Hypertriglyceridaemia
- Focus Pharmacodynamics
- Acronyms FluvaBAT
- 28 May 2018 Status changed from recruiting to completed.
- 21 Jun 2017 New trial record